Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Intravenous Infusion Pumps Market Size, Value And Growth Trajectory Through 2030#_x000D_
The intravenous infusion pumps market size has seen substantial growth in recent years. Projections indicate it will expand from $6.37 billion in 2025 to $6.98 billion in 2026, at a compound annual growth rate (CAGR) of 9.5%. The historical growth experienced by the market can be attributed to factors such as the expansion of hospital infrastructure, an increase in the use of intravenous drug delivery, the rising prevalence of chronic diseases, the adoption of programmable infusion systems, and improvements in pump accuracy and reliability._x000D_
_x000D_
The intravenous infusion pumps market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $9.98 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.4%. This projected growth stems from several factors, including a heightened need for interoperable infusion devices, an increasing emphasis on patient-centric care models, the broadening scope of remote patient monitoring, greater investments in smart healthcare infrastructure, and the rising uptake of home-based infusion therapies. Furthermore, significant developments expected during this period involve the greater deployment of smart infusion pumps, increased utilization of dose error reduction software, enhanced integration of connected hospital systems, the expansion of ambulatory and home infusion therapies, and a reinforced commitment to medication safety._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Intravenous Infusion Pumps Market Growth Catalysts And Demand Drivers#_x000D_
The growing incidence of bleeding disorders is anticipated to drive expansion in the intravenous infusion pump market. These are medical conditions that hinder the body’s ability to form blood clots effectively. The rise in such disorders stems from genetic predispositions and an increase in consanguineous marriages, heightening the likelihood of inherited clotting deficiencies within communities. Intravenous infusion pumps serve as a crucial therapeutic instrument for managing bleeding issues, as they ensure precise and controlled delivery of essential medications, thereby guaranteeing patients receive the correct dosage at the appropriate moment. An illustration of this is the data from April 2025 by Pfizer, a US-based biopharmaceutical company, stating that over 11,800 individuals were afflicted with haemophilia A or B in the United Kingdom during 2023 to 2024. Globally, this condition affects more than 800,000 people and is predominantly identified in early childhood. Consequently, the escalating occurrence of bleeding disorders is set to fuel the expansion of the intravenous infusion pump market moving forward._x000D_
_x000D_
#Intravenous Infusion Pumps Market Segment Analysis And Revenue Potential#_x000D_
The intravenous infusion pumps market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Volumetric, Syringe, Enteral, Ambulatory, IV Disposables, Other Products _x000D_
2) By Application: Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Other Applications _x000D_
3) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Treatment Centers, Specialty Clinics, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Volumetric: Large-volume Pumps, Small-volume Pumps _x000D_
2) By Syringe: Micro Syringe Pumps, Macro Syringe Pumps _x000D_
3) By Enteral: Portable Enteral Pumps, Stationary Enteral Pumps _x000D_
4) By Ambulatory: Patient-controlled Analgesia (PCA) Pumps, Insulin Pumps, Disposable Pumps _x000D_
5) By IV Disposables: IV Tubing Sets, IV Catheters, IV Cannulas, IV Solutions _x000D_
6) By Other Products: Implantable Pumps, Smart Pumps, Elastomeric Pumps _x000D_
_x000D_
#Intravenous Infusion Pumps Market Trends Shaping Long-Term Demand#_x000D_
Leading companies within the intravenous infusion pumps market are prioritizing technological advancements, particularly real-time flow monitoring systems, to dynamically detect and correct deviations in infusion rates, thereby enhancing precision and patient well-being. These real-time flow monitoring systems are sophisticated medical instruments designed to continuously measure and track the flow rate of liquids, such as medications or blood, instantaneously to ensure their exact and prompt administration during treatment. For instance, in February 2023, Mindray, a manufacturer of high-tech medical devices based in China, introduced its BeneFusion I-/U Series infusion systems. These systems integrate Smart Accurate™ technology, which constantly observes the actual drug flow rate and offers immediate feedback to rectify any inconsistencies. The pumps also feature elegant, user-friendly interfaces with full-touch screens, a customizable drug library, and a patented BolusGUARD motorized syringe loading mechanism designed to prevent accidental boluses during the loading process. Furthermore, they facilitate connectivity through Mindray’s M-IoT system, enabling centralized device management, analytical insights into maintenance, and updates to the drug library, thus strengthening safety and operational efficiency throughout hospital networks._x000D_
_x000D_
#Intravenous Infusion Pumps Market Key Participants And Competitive Landscape#_x000D_
Major companies operating in the intravenous infusion pumps market are B. Braun Melsungen AG, Baxter International Inc., Medtronic plc, Fresenius Kabi AG, Smiths Medical Inc., Becton Dickinson and Company (BD), Terumo Corporation, F. Hoffmann-La Roche Ltd., ICU Medical Inc., IRadimed Corporation, Mindray Medical International Limited, Zyno Medical LLC, Tandem Diabetes Care Inc., Johnson & Johnson, Micrel Medical Devices SA, Q-Core Medical Ltd., Moog Inc., Roche Diagnostics International AG, Nipro Corporation, Animas Corporation, Ypsomed Holding AG, Valeritas Inc., ZOLL Medical Corporation, Codan Medical A/S, Halyard Health Inc., InfuSystem Holdings Inc., Hospira Infusion Systems, CareFusion Corporation _x000D_
_x000D_
#View The Full Intravenous Infusion Pumps Market Report:#_x000D_
_x000D_
#Intravenous Infusion Pumps Market Geographic Analysis: Where Is Demand Rising Fastest?#_x000D_
North America was the largest region in the intravenous infusion pumps market in 2025. Western Europe was the second-largest region in the intravenous infusion pumps market. The regions covered in the intravenous infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
